Key Highlights
- Entact Bio appoints Ruben Tommasi, Ph.D., as Chief Scientific Officer.
- Dr. Tommasi brings 30 years of drug discovery leadership across multiple therapeutic areas.
- Tommasi previously served at Dunad Therapeutics and Entasis Therapeutics, driving successful clinical outcomes.
- Entact Bio focuses on precision medicines that enhance beneficial protein function via the Encompass™ platform.
Source: Business Wire
Notable Quotes
- “We’re thrilled to welcome Ruben, who brings deep expertise in drug discovery and has a proven record in successfully advancing compounds from program inception to clinical development and regulatory approval.” — Victoria Richon, Ph.D., CEO at Entact Bio
- “I was very attracted to the innovative modality Entact is developing as it holds tremendous potential to pursue new, undrugged targets believed to be beneficial against disease.” — Ruben Tommasi, Ph.D., Chief Scientific Officer at Entact Bio
SoHC's Take
The appointment of Dr. Ruben Tommasi as Chief Scientific Officer marks a pivotal moment for Entact Bio. His extensive experience in drug discovery, particularly in progressing compounds through to FDA approval, will likely accelerate the development of Entact’s innovative ENTAC™ medicines. With a proven track record across multiple therapeutic areas, Dr. Tommasi’s leadership will strengthen the company’s ability to explore novel therapeutic targets and address diseases that current treatments cannot effectively reach. This strategic move positions Entact Bio to further expand its impact on precision medicine, potentially offering new hope to patients in underserved disease areas.
Heading
Key Highlights Novo Nordisk partners with Hims & Hers, LifeMD, and Rofor streamlined Wegovy® access through telehealth.Wegovy® now available at ...
Key Highlights Ro now offers all Wegovy® doses for $499/month via NovoCare® PharmacyDirect access to FDA-approved GLP-1 medication through the ...
Episode Details: Join us on the latest episode, hosted by Jared S. Taylor! Our Guest: Dr. Jim Bonnette, Chief Medical ...
Key Highlights 28% reductionin documentation time for care teams20% increasein patient engagement through automated outreachAI Agentsmanage SMS/voice outreach, scheduling, and ...
Key Highlights Warner Roberts appointed as Calibrate’s Chief Commercial OfficerWill lead commercial strategy to scale workplace obesity solutionsCalibrate members report ...
Key Highlights Fully integratedwith Castlight’s healthcare benefits app 24/7 on-demand carevia chat, video, and voice High-quality carefor common conditions delivered ...
